Lantern Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
10,127
+1,201
+13% +$96.9K 0.36% 68
2026
Q1
$773K Sell
8,926
-662
-7% -$63.4K 0.4% 66
2025
Q4
$921K Buy
9,588
+478
+5% +$46.4K 0.49% 55
2025
Q3
$868K Sell
9,110
-200
-2% -$18.4K 0.46% 54
2025
Q2
$812K Buy
+9,310
New +$790K 0.48% 57
2024
Q4
$756K Sell
9,469
-1,468
-13% -$127K 0.49% 50
2024
Q3
$985K Sell
10,937
-1
-0% -$84 0.68% 41
2024
Q2
$861K Hold
10,938
0.62% 44
2024
Q1
$953K Buy
10,938
+223
+2% +$19K 0.67% 44
2023
Q4
$883K Buy
+10,715
New +$817K 0.69% 41

Other funds holding MDT

Lantern Wealth Advisors's MDT Position: Q2 2026 in Review

Lantern Wealth Advisors increased its Medtronic (MDT) stake by 13% in Q2 2026, buying an estimated $96.9K and bringing the position to 10,127 shares worth $792K. The position accounts for 0.36% of the portfolio, ranked #68.

Lantern Wealth Advisors first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $985K in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lantern Wealth Advisors held 10,127 shares of Medtronic worth $792K as of Q2 2026.
  • Lantern Wealth Advisors bought 1,201 Medtronic shares in Q2 2026, an estimated $96.9K.
  • Medtronic made up 0.36% of Lantern Wealth Advisors's portfolio in Q2 2026, its #68 holding.
  • Lantern Wealth Advisors first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Lantern Wealth Advisors's Medtronic position peaked at $985K in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lantern Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.